249 related articles for article (PubMed ID: 33289280)
1. High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial.
Hui D; Mahler DA; Larsson L; Wu J; Thomas S; Harrison CA; Hess K; Lopez-Mattei J; Thompson K; Gomez D; Jeter M; Lin S; Basen-Engquist K; Bruera E
Oncologist; 2021 Aug; 26(8):e1470-e1479. PubMed ID: 33289280
[TBL] [Abstract][Full Text] [Related]
2. High-Flow Oxygen and High-Flow Air for Dyspnea in Hospitalized Patients with Cancer: A Pilot Crossover Randomized Clinical Trial.
Hui D; Hernandez F; Urbauer D; Thomas S; Lu Z; Elsayem A; Bruera E
Oncologist; 2021 May; 26(5):e883-e892. PubMed ID: 33289276
[TBL] [Abstract][Full Text] [Related]
3. High-Flow Nasal Cannula Versus Conventional Oxygen Therapy in Relieving Dyspnea in Emergency Palliative Patients With Do-Not-Intubate Status: A Randomized Crossover Study.
Ruangsomboon O; Dorongthom T; Chakorn T; Monsomboon A; Praphruetkit N; Limsuwat C; Surabenjawong U; Riyapan S; Nakornchai T; Chaisirin W
Ann Emerg Med; 2020 May; 75(5):615-626. PubMed ID: 31864728
[TBL] [Abstract][Full Text] [Related]
4. A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients.
Takase E; Akamatsu H; Teraoka S; Nakaguchi K; Tanaka M; Kaki T; Furuta K; Sato K; Murakami E; Sugimoto T; Shibaki R; Fujimoto D; Hayata A; Tokudome N; Ozawa Y; Koh Y; Nakanishi M; Kanai K; Shimokawa T; Yamamoto N
J Pain Symptom Manage; 2024 Mar; 67(3):204-211.e1. PubMed ID: 37992848
[TBL] [Abstract][Full Text] [Related]
5. Enhancing exercise tolerance in interstitial lung disease with high-flow nasal cannula oxygen therapy: A randomized crossover trial.
Yanagita Y; Arizono S; Yokomura K; Ito K; Machiguchi H; Tawara Y; Katagiri N; Iida Y; Nakatani E; Tanaka T; Kozu R
Respirology; 2024 Jun; 29(6):497-504. PubMed ID: 38387607
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial.
Hui D; Hernandez F; Larsson L; Liu D; Kilgore K; Naberhuis J; Virgilio A; Reddy S; Reddy A; Dalal S; Haider A; Driver L; Azhar A; Dev R; Bruera E
J Pain Symptom Manage; 2019 Oct; 58(4):605-613. PubMed ID: 31276809
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of non-invasive ventilation as a rescue therapy for relieving dyspnea in patients with stable severe COPD.
Ou YE; Lin ZM; Wu WL; Luo Q; Chen RC
Respir Med; 2016 Dec; 121():74-80. PubMed ID: 27888995
[TBL] [Abstract][Full Text] [Related]
8. Effects of heated and humidified high flow gases during high-intensity constant-load exercise on severe COPD patients with ventilatory limitation.
Cirio S; Piran M; Vitacca M; Piaggi G; Ceriana P; Prazzoli M; Paneroni M; Carlucci A
Respir Med; 2016 Sep; 118():128-132. PubMed ID: 27578482
[TBL] [Abstract][Full Text] [Related]
9. The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial.
Suzuki A; Ando M; Kimura T; Kataoka K; Yokoyama T; Shiroshita E; Kondoh Y
BMC Pulm Med; 2020 Feb; 20(1):51. PubMed ID: 32093665
[TBL] [Abstract][Full Text] [Related]
10. Automated O
Vézina FA; Bouchard PA; Breton-Gagnon É; Dion G; Viglino D; Roy P; Bilodeau L; Provencher S; Denault MH; Saey D; Lellouche F; Maltais F
Respir Care; 2023 Jul; 69(1):1-14. PubMed ID: 37491073
[TBL] [Abstract][Full Text] [Related]
11. Bilevel exercise training and directed breathing relieves exertional dyspnea for male smokers.
Gimenez M; Saavedra P; Martin N; Polu JM; López D; Gómez A; Servera E
Am J Phys Med Rehabil; 2012 Oct; 91(10):836-45. PubMed ID: 22760109
[TBL] [Abstract][Full Text] [Related]
12. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.
Beeh KM; Watz H; Puente-Maestu L; de Teresa L; Jarreta D; Caracta C; Garcia Gil E; Magnussen H
BMC Pulm Med; 2014 Dec; 14():209. PubMed ID: 25539654
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-flow nasal cannula oxygen therapy on exercise tolerance in patients with idiopathic pulmonary fibrosis: A randomized crossover trial.
Harada J; Nagata K; Morimoto T; Iwata K; Matsunashi A; Sato Y; Tachikawa R; Ishikawa A; Tomii K
Respirology; 2022 Feb; 27(2):144-151. PubMed ID: 34729862
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea.
Bruera E; Sweeney C; Willey J; Palmer JL; Strasser F; Morice RC; Pisters K
Palliat Med; 2003 Dec; 17(8):659-63. PubMed ID: 14694916
[TBL] [Abstract][Full Text] [Related]
15. Supplemental Oxygen During High-Intensity Exercise Training in Nonhypoxemic Chronic Obstructive Pulmonary Disease.
Neunhäuserer D; Steidle-Kloc E; Weiss G; Kaiser B; Niederseer D; Hartl S; Tschentscher M; Egger A; Schönfelder M; Lamprecht B; Studnicka M; Niebauer J
Am J Med; 2016 Nov; 129(11):1185-1193. PubMed ID: 27427325
[TBL] [Abstract][Full Text] [Related]
16. Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.
Hui D; Kilgore K; Park M; Williams J; Liu D; Bruera E
J Pain Symptom Manage; 2016 Oct; 52(4):459-468.e1. PubMed ID: 27401508
[TBL] [Abstract][Full Text] [Related]
17. Domiciliary High-Flow Nasal Cannula Oxygen Therapy for Patients with Stable Hypercapnic Chronic Obstructive Pulmonary Disease. A Multicenter Randomized Crossover Trial.
Nagata K; Kikuchi T; Horie T; Shiraki A; Kitajima T; Kadowaki T; Tokioka F; Chohnabayashi N; Watanabe A; Sato S; Tomii K
Ann Am Thorac Soc; 2018 Apr; 15(4):432-439. PubMed ID: 29283682
[TBL] [Abstract][Full Text] [Related]
18. A randomized cross-over trial on the direct effects of oxygen supplementation therapy using different devices on cycle endurance in hypoxemic patients with Interstitial Lung Disease.
Edvardsen A; Jarosch I; Grongstad A; Wiegand L; Gloeckl R; Kenn K; Spruit MA
PLoS One; 2018; 13(12):e0209069. PubMed ID: 30592724
[TBL] [Abstract][Full Text] [Related]
19. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD.
Eves ND; Sandmeyer LC; Wong EY; Jones LW; MacDonald GF; Ford GT; Petersen SR; Bibeau MD; Jones RL
Chest; 2009 Mar; 135(3):609-618. PubMed ID: 19017883
[TBL] [Abstract][Full Text] [Related]
20. Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.
Hui D; Kilgore K; Frisbee-Hume S; Park M; Liu D; Balachandran DD; Bruera E
J Pain Symptom Manage; 2017 Dec; 54(6):798-805. PubMed ID: 28803087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
